SCHEMBL7962373

SCHEMBL7962373

CCOC(=O)c1c(C)c(C(C)=O)c(OC(C)=O)n1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.58
USP2 O75604 2/20 0.48
TSHR P16473 5/20 0.47
HPGD P15428 4/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
THRB P10828 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 2/20 0.40
GAA P10253 2/20 0.40
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8910221 0.81 KMT2A (0.81) KMT2AUSP2TSHRHPGDCYP1A2
SCHEMBL8910153 0.78 KMT2A (0.56) KMT2AUSP2TSHRHPGDCYP1A2
SCHEMBL11363402 0.74 KMT2A (1.00) KMT2AUSP2TSHRHPGDCYP1A2
SCHEMBL16416778 0.69 KMT2A (0.76) KMT2AUSP2TSHRHPGDCYP1A2
SCHEMBL9695869 0.69 KMT2A (0.53) KMT2AUSP2TSHRHPGDCYP1A2
SCHEMBL16416876 0.69 KMT2A (0.76) KMT2AUSP2TSHRHPGDCYP1A2
SCHEMBL257221 0.69 KMT2A (0.69) KMT2AUSP2TSHRHPGDCYP1A2
SCHEMBL11063288 0.68 KMT2A (0.64) KMT2AUSP2TSHRHPGDCYP1A2
SCHEMBL23123196 0.67 KMT2A (0.46) KMT2AUSP2L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL26542538 0.67 KMT2A (0.71) KMT2AUSP2TSHRHPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201129-B1 ANTICARCINOGENIC AGENTS UNIV. COLLEGE CARDIFF CONSULTANTS (GB) 2001-03-13 US disclosed
WO-1995021171-A1 TRICYCLIC DERIVATIVES AND THEIR USE AS ANTI-CANCER AGENTS UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 1995-08-10 WO disclosed